.png?width=700&name=New-ATE-Logo2019%20(1).png)
A Breakthrough AAV Enhancer to Improve
Titers and Reduce Production Costs with Any
Serotype, Suspension HEK Cell Type,
and Transfection Reagent
Presenter:
Leisha Kopp
Senior Field Applications Scientist,
Senior Field Applications Scientist,
Mirus Bio
Leisha Kopp is a senior field applications scientist at Mirus Bio, a company committed to equipping biopharmaceutical innovators with next generation transfection solutions for all cell culture applications. Leisha has 20 years of molecular biology and mammalian cell culture experience in industrial labs and has worked extensively with an array of primary and immortalized mammalian cells. Her combined bench and biopharma knowledge enables support of scientists in all stages of the drug discovery process to develop optimized and scalable processes that deliver complex therapies to patients more quickly. Leisha is a graduate of the University of Wisconsin-Madison, with key interests in viral vector manufacturing and gene therapy.
